OnCo
institutionsInstitution

National Cancer Centre Singapore

aka NCCS, SingHealth Duke-NUS Oncology Academic Clinical Programme

Singapore's national cancer centre and the largest cancer facility in the country, with a proton centre and leading Asian research in liver and lung cancer genomics.

The National Cancer Centre Singapore opened in 1999 and moved into a new purpose-built building on the Outram campus in 2023 that houses South-east Asia's first hospital-based proton therapy centre (Goh Cheng Liang Proton Therapy Centre). It treats the majority of Singapore's public-sector cancer patients and, with Duke-NUS Medical School and the Genome Institute of Singapore, has produced influential research on Asian lung cancer in never-smokers, hepatocellular carcinoma and cholangiocarcinoma genomics (including the liver-fluke associated cholangiocarcinoma genome), nasopharyngeal cancer and cancer immunotherapy. NCCS runs the Singapore Translational Cancer Consortium, a large phase 1 unit, and cell therapy programmes with the Singapore Immunology Network, and it coordinates national screening and survivorship initiatives.

Location
Singapore, SG
Type
cancer center · Duke-NUS Medical School
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#122 · 32 points (0 Newsweek + 0 NCI + 32 from 16 linked objects) · ranking

Programmes

5top
  • Proton therapy
  • Asian lung and liver cancer genomics
  • Phase 1 unit
  • Cholangiocarcinoma research
  • Cell therapy

Connected

16top

Pages like this

not linked directly; found by shared links